SciELO - Scientific Electronic Library Online

vol.141 número4Isapres, tribunal constitucional y distribución del derecho a cuidado sanitarioPénfigo vulgar tipo cutáneo: Caso clínico índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




Links relacionados


Revista médica de Chile

versão impressa ISSN 0034-9887


VEGA, Jorge; RODRIGUEZ, María De Los Ángeles; GOECKE, Helmuth  e  SANTAMARINA, Mario. Hemophagocytic syndrome after kidney transplant in a patient with hereditary nephritis. Report of one case. Rev. méd. Chile [online]. 2013, vol.141, n.4, pp.519-524. ISSN 0034-9887.

We report a 28-year-old male with a hereditary nephritis (Alport Syndrome) on hemodialysis for 5 years, who received a kidney graft from a deceased donor. Cyclosporine (CsA), mycophenolate mofetil (MMF) and steroids were prescribed. In the postoperative period the patient had thrombophlebitis and diarrhea. A CT sean showed splenomegaly, ascites, bilateral pleural effusion and bowel edema. Laboratory showed hypoalbuminemia, increased C reactive protein (CRP) and panhypogammaglobulinemia. At day 32 after transplantation, an acute rejection (Banff II b) was diagnosed and treated with methylprednisolone, replacing CsA by tacrolimus. The acute rejection was controlled but six days later, high fever, pancytopenia and hyperferritinemia appeared. A bone marrow smear showed numerous histiocytes and hemophagocytosis. Hemophagocytic syndrome was diagnosed. MMF and tacrolimus were withdrawn and CsA was reinstituted. Fever fell quickly, CPR normalized at 24 hours and white blood cell count at 72 hours. Days later, the concentrations of albumin, immunoglobulins and hematological parameters normalized. The patient was discharged on day 57 after admission in good condition.

Palavras-chave : Lymphohistiocytosis, hemophagocytic; Mycophenolate mofetil; Nephritis, hereditary; Organ transplantation.

        · texto em Espanhol     · Espanhol ( pdf )


Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons